"In KwaZulu-Natal, among women aged 15 to 29, it is 56.8%." The Africa Centre trial in northern KwaZulu-Natal compared what happened in 22 clusters of 1,000 people: half were randomly allocated to test and treat, half told they would be given drugs when their CD4 count dropped below 350 (500 when government guidelines later changed).
42 children were randomly allocated to test and 44 to control group.
The patients were randomly allocated to test group and control group at a ratio of 2 1.
Bulls born between 1998 and 2002 represented five single year cohorts and were allocated to test sets according to their year of birth.
Primary outcome data were available for 82 of 101 and 78 of 99 participants allocated to test and control groups, respectively; the remainder died prior to final follow-up.
When the tumour volume reached approximately 100 mm on day 14 after the tumour inoculation, the mice were randomly allocated to test groups of about four or five mice each, and started the treatment on the same day.
For this experiment, the 200 test items were divided into two subsets of 100 items, tests A and B. Items across radiological subdomains and across item writers were evenly allocated to test A and B. The 200 items were constructed following the normal procedure, and subsequently all items per subdomain and item writer were split up into two subsets to compose two 'parallel' tests of 100 items.
In contrast to the previous scenarios, new testing resources may now be allocated to targeted testing for MSM, targeted testing for IDU-FSW, routine testing in high prevalence settings for MSM, routine testing in high prevalence settings for IDU-FSW, or routine testing in acute care.
Participants were randomly allocated to genetic testing versus no testing.
For a cost ratio of 9 1 and a budget increase of 200 %, approximately 39%% of testing resources should be allocated to routine testing in acute care and the balance to routine testing in high prevalence settings.
